NASDAQ:MEIP - MEI Pharma, Inc.
$2.10
 $0.02
+0.96%
4:00PM EDT
2019-07-15
MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and PWT143. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of advanced hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. PWT143 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MEIP     avg for
industry  
  avg for
sector  
42 stocks weight:  7. 96   114. 77   204. 78  
42 stocks rank:  4. 01 K 1. 44 K 810. 33  
# analyst opinions:  8. 00   13. 59   13. 86  
mean recommendation:  1. 50   2. 12   2. 04  

quick ratio:  6. 99   5. 48   1. 89  
current ratio:  7. 21   5. 85   2. 40  

target price low:  5. 50   82. 72   115. 11  
target price avg:  2. 65   104. 42   138. 02  
target price high:  3. 50   130. 64   159. 47  
1-yr high:  4. 61   110. 27   142. 72  
last close:  2. 08   85. 12   126. 54  
50-day avg:  2. 73   86. 06   122. 35  
200-day avg:  2. 96   88. 76   121. 75  
1-yr low:  1. 92   69. 26   100. 63  
volume:  192. 06 K 3. 51 M 5. 53 M
50-day avg volume:  452. 75 K 3. 21 M 4. 22 M
200-day avg volume:  285. 49 K 3. 04 M 4. 75 M

1-day return:  -0. 48 % -0. 30 % -1. 01 %
this week return:  -9. 57 % -2. 16 % -1. 35 %
12-wk return:  -28. 77 % 3. 34 % 8. 69 %
52-wk return:  -49. 88 % -1. 76 % 12. 22 %

enterprise value (EV):  66. 71 M 46. 50 B 123. 99 B
market cap:  148. 28 M 40. 77 B 109. 11 B
EBITDA:  -41. 91 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -1. 59   5. 45   12. 05  
enterprise/revenue (EV/R):  15. 39   50. 46   9. 50  
total revenue:  4. 33 M 10. 21 B 40. 60 B
total debt:  0. 00   11. 27 B 17. 58 B
net income (common):  -39. 12 M 2. 13 B 4. 27 B

shares outstanding:  37. 32 M 551. 08 M 1. 24 B
shares:  50. 37 M 559. 41 M 1. 22 B
shares short:  1. 42 M 11. 15 M 11. 94 M
shares short prior month:  275. 18 K 9. 31 M 11. 96 M
short ratio:  2. 05   5. 72   3. 43  
short % of float:  2. 01 % 6. 40 % 2. 65 %
total cash/share:  1. 15   11. 00   9. 23  
total cash:  82. 29 M 6. 03 B 6. 01 B
free cash flow:  -15. 44 M 3. 02 B 4. 96 B
operating cash flow:  -25. 11 M 3. 92 B 5. 99 B

book value:  0. 53   13. 02   27. 49  
price/book:  3. 92   4. 21   8. 80  
gross profits:  -1. 76 M 7. 67 B 36. 29 B
operating margins:  -968. 61 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  1. 50 % 36. 11 % 55. 16 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 50 % 1. 08 %

1-yr EPS:  -0. 94   2. 12   4. 26  
forward EPS:  -0. 77   3. 47   7. 14  
P/E:  -2. 22   2. 15   33. 17  
forward P/E:  -2. 70   -4. 03   17. 60  
PE/G:  -0. 01   0. 54   0. 34  
growth:  188. 50 % 263. 03 % 78. 34 %
earnings high:  -0. 13   0. 91   1. 70  
earnings avg:  -0. 20   0. 71   1. 58  
earnings low:  -0. 38   0. 48   1. 46  
revenue high:  2. 40 M 2. 64 B 11. 26 B
revenue avg:  710. 00 K 2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -42. 54 % -2. 31 % 5. 31 %
return on equity:  -110. 53 % -82. 48 % 135. 30 %
revenue growth:  188. 50 % 262. 60 % 72. 94 %
revenue/share:  0. 07   12. 77   61. 38  

beta (1yr vs S&P500):  0. 72   1. 26   0. 91  
sharpe (1yr):  -0. 99   0. 07   0. 77  

held % insiders:  0. 78 % 6. 08 % 3. 31 %
held % institutions:  58. 14 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : MEIP
.    101.263 =       101.263 :: --> INITIAL WEIGHT <--
.    - 0.938 =       100.325 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.005 =       201.113 :: P/E factor
.    x 2.209 =        444.25 :: PE/G factor
.    x 1.566 =       695.915 :: beta factor
.    x 0.996 =       692.848 :: sharpe factor
.    x 2.768 =      1918.023 :: current ratio factor
.     x 1.08 =      2071.999 :: quick ratio factor
.     x 1.22 =      2527.333 :: short ratio factor
.    x 2.449 =      6190.219 :: revenue growth factor
.    x 1.305 =        8078.8 :: EV/R factor
.    x 1.047 =      8461.669 :: price-to-book factor
.                               --> PERFORMANCE <--
.    x 2.114 =     17887.836 :: sector+industry 1-year gains factor
.    x 1.033 =     18485.254 :: industry 12-weeks return factor
.    x 1.305 =     24128.316 :: industry 2-weeks return factor
.     x 0.98 =     23652.461 :: "drift" penalty 2 days ago
.    x 0.978 =     23131.415 :: "drift" penalty 4 days ago
.    / 1.932 =     11970.991 :: overall "drift" factor
.    x 0.926 =     11085.108 :: largest single-day jump factor
.    x 0.066 =       734.113 :: low price factor
.    x 0.164 =       120.711 :: notable returns + performance factor
.                               --> PROJECTIONS <--
.     x 0.77 =        92.947 :: forward EPS factor
.    x 0.916 =        85.179 :: forward P/E factor
.    x 1.182 =        100.72 :: industry recommendation factor
.    x 3.016 =       303.743 :: company recommendation factor
.    x 1.008 =       306.066 :: factor historical industry gain for week 28
.   x 11.039 =      3378.791 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =         7.624 :: reduced for readability
.    + 0.331 =         7.955 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                      7.955 :: FINAL WEIGHT for NASDAQ:MEIP


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org